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Summary The use o f m am m ography in recent years has resulted in an increase in the detection of small breast 
cancers. The beneficial effects o f  early detection on breast cancer mortality seem to differ with age. To obtain 
more insight into this m atter we studied the long-term prognosis of patients with early invasive breast cancers 
(T l) in three age groups: 144 patients of age 40 -49, 402 patients o f age 5 0 -6 9  and 192 patients 70 years or 
older at diagnosis. In all age groups, patients with a tumour o f 1 cm or less have a longer breast cancer .specific 
survival than patients with a tum our larger than 2 cm. The survival advantage in the case of tumours o f a size 
rounded to 1.5 cm compared with tumours larger than 2 cm in the under age 50 group was marginal (and not 
significant). However, older patients with tumours of this size do have a significantly improved survival. H is 
m ore difficult to improve survival in younger patients through early detection, partly because of an apparent 
early metastatic potential o f  their tumours. A reduction in breast cancer mortality might be expected in women 
younger than 50 years o f age only if a substantial proportion of the invasive cancers are detected before their 
size exceeds 1 cm.
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In recent years an increase in the diagnosis of early stage and 
small breast cancers has been reported (Miller et al., 1993; 
Nab et a i , 1993). This will be mainly due to the substantial 
increase in the use of mammography for screening purposes 
or case finding.
Randomised trials have shown that advanced detection by 
mammographic screening in women 50 years of age or older 
can result in a reduction of breast cancer mortality (Hurley 
and Kaldor, 1992; Fletcher et al,, 1993). The beneiit of 
mammographic screening in younger women is not clear 
(Fletcher et al., 1993). This may be owing to factors relating 
to the screening process itself, such as the sensitivity of the 
mammographic screening test and the frequency of screening. 
However, an explanation may also be found in the biology of 
the tumour. To provide insight into the nature of breast 
cancer, survival curves by age group and stage of the tumour 
are compared (Tabar et a i 1993; Byrne et al., 1994). A clear 
trend of increased survival with decreasing size is demon- 
strated in all age groups. However, small tumours detected by 
screening mammography may have a lower malignant 
potential than small cancers detected by the woman herself 
(Kleini et al., 1992; Tabar et al,, 1992). The malignant 
potential of breast cancers varies considerably between 
tumours, one factor being differences in growth rate (Peer 
et al,, 1993). Slow-growing tumours have a longer mammo- 
graphically detectable preclinical phase. Therefore the like­
lihood of being detected at screening is greater for slow- 
growing than for faster growing tumours (‘length-time 
bias’). Consequently, a small invasive tumour detected by 
screening might have a better prognosis than a clinically 
diagnosed cancer of the same size. To study the prognosis of 
small breast cancers, it is therefore important to take account 
of the mode of detection, i.e. clinically diagnosed vs screen 
detected. Since 1975 in Nijmegen a biennial mammographic 
screening programme has been conducted for women over 
age 35 at the start of the project (Peer et id., 1994). The 
follow-up of breast cancer patients, either clinically diagnosed 
or detected at a screening examination, provides an
opportunity to study the breast cancer specific survival of 
the patients over an 18 year period, in particular the survival 
of those with invasive tumours 2 cm or less in size (Tl),
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Patients and methods
Since 1975, data on all Nijmegen patients diagnosed as 
having breast cancer in either one of the two Nijmegen 
hospitals have been carefully recorded by the local cancer 
registry of the Departments of Diagnostic Radiology and 
Pathology of the Nijmegen University Hospital and of the 
Canisius Wilhclmina Hospital. On record at the end of 1992 
were 1333 patients, 40 years of age or older, diagnosed with 
primary breast cancer. Patients with lobular carcinomas in 
situ were not included because they are not treated as breast 
cancer patients. Cancers were detected either in the screened 
population at a screening examination (// = 538) or in the 
interval between the scheduled examinations, or among non- 
participants of the programme or before the first screening 
invitation.
Tumour size of invasive lesions was determined mammo- 
graphically. If the diameter could not be assessed mammo- 
graphically, the histologically determined diameter was 
substituted (in 10% of the measurements). Tumour size was 
available in all but 19 of the invasive cases. There was a clear 
tendency to round measurements to the nearest 0.5 cm. 
Therefore we used the following categories of tumour size:
1 cm or less, 1.5 cm, 2 cm, 2.5-4.5 cm, 5 cm or larger.
The vital status of the Nijmegen breast cancer patients was 
acquired from the local registrar’s office. At the end of 1993, 
478 of the 1333 patients had died. All clinical information on 
these patients was gathered to classify the cause of death, i.e. 
either breast cancer or another cause. Breast cancer was 
considered to be the underlying cause of death when distant 
metastases had been reported before death and competing 
causes of death could be ruled out. For ten patients the cause 
of death could not be assessed. Five of them were diagnosed 
with early invasive breast cancer, i.e. involving a tumour
2 cm or less in diameter.
Breast cancer specific survival curves obtained with the 
life-table method (Lee, 1980), were calculated for patients 
diagnosed with in situ ductal cancers and invasive tumours by 
size groups and for three age groups: 40-49, 50- 69, >70 
years of age at diagnosis. Deaths from causes other than 
breast cancer were treated as censored observations in the
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survival analysis. The survival advantage with decreasing size 
was expressed as the ratio of the hazards of dying from 
breast cancer. Adjustment for the detection mode, i.e. screen- 
detected or clinically diagnosed, was accomplished with a 
proportional hazards regression analysis, applied by age 
group (Lee, 1980).
Results
Among the 260 younger patients, being 40™ 49 years at 
diagnosis, 144 patients were diagnosed with a small (2 cm or 
less) invasive breast tumour. Of the 672 patients in the 50 -  69 
age group, 402 patients had a small invasive tumour and in 
the older age group (> 70  years) 401 patients were diagnosed, 
of whom 192 had a small invasive tumour.
The breast cancer survival curves by size of the tumour for 
each of the three age groups are displayed in Figures 1 -3 , 
The 5-, 10- and 15 year breast cancer specific survival rates 
for younger patients (40-49 years) diagnosed with a small 
invasive tumour of 2 cm or less were 88%, 75% and 66% 
respectively. The corresponding survival percentages for 
patients in the 50-69 age group were 92%, 78% and 73% 
respectively. In the oldest age group (>70 years) 90% and 
83% of the patients did not die from breast cancer within 5 
and 10 years respectively, after diagnosis. The number of 
older patients at risk of dying from breast cancer after 15 
years of follow-up was too small to calculate the 15 year 
breast cancer specific survival for the >70 age group. Table I 
shows the relative hazards of death from breast cancer for 
patients with small invasive cancers ( ^ 2  cm), relative to the 
hazard of the 2.5-4.5 cm size group for the different age 
categories. Only in the oldest age group (> 70  years) is there
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Figure I Breast cancer survival for patients 40 49 years of age 
at diagnosis with DCIS and invasive breast cancer by tum our size. 
Between parentheses: number o f breast cancer deaths/num ber o f  
breast cancer patients. • ,  DCIS (0/37); O . ^ l o m  (5/39); ■ ,  
1.5 cm (8/49); □ ,  2cm (15/56); A ,  2.5 4 .5cm (17/58); A ,  £ 5 cm 
(9/17).
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Figure 2 Breast cancer survival for patients 5 0 -6 9  years o f age 
at diagnosis with DCIS and invasive breast cancer by tum our size. 
Between parentheses: number o f breast cancer deaths/num ber of 
breast cancer patients. 0 ,  DCIS (1/65); O i < l c m  (17/I55); ■  , 
l .5 cm (18 /130); □ ,  2cm  (33/115); A ,  2 .5 -4 .5 c m  (47/148); A , 
> 5  cm (25/52).
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Figure 3 Breast cancer survival for patients > 70  years of age at 
diagnosis with DCIS and invasive breast cancer by tumour size. 
Between parentheses: number o f  breast cancer deaths/number of 
breast cancer pa Lien is. D CIS (0/22); O , ^ l e m  (3/56); 
1.5cm (8/59); □  , 2cm (10/74); A , 2 . 5 4.5cm (28/131); A , 
> 5  cm (20/40).
an indication that patients with tumours of a size rounded to 
2 cm have a better prognosis than patients with tumours 
2 .5 -4 .5  cm in size. The survival advantage for patients with 
tumours of a size rounded to 1.5 cm (compared with tumours 
of 2.5” 4.5 cm) in the under 50 age group was marginal (and 
not significant). However, patients with tumours of this size 
in the above 50 age groups have a significantly improved 
survival. In all age groups patients with tumours of 1 cm or 
less have a better survival than patients with tumours larger 
than 2 cm.
Part of the survival advantage of the patients with small 
invasive tumours might be explained by a more favourable 
biology of the screen-detected small tumours ('length- time 
bias’). In younger women 35% (50/144) of the small invasive 
tumours (< 2  cm) were detected at a screening examination, 
In the 50- to 69-year-old age group this percentage was 59% 
(238/402) and in the oldest age group 46% (89/192). To 
adjust for the possible confounding effect of detection mode, 
a proportional hazards model was employed that incorpo­
rates size and the mode of detection, that is, screen-detected 
or clinically diagnosed (Table II). The results show that the 
survival advantages for patients with tumours of 2 cm or less 
(compared with larger tumours) decrease only marginally.
Table I H azard ratio of dying from breast cancer for patients 
diagnosed with early invasive breast cancer («*2 cm) with reference 
to patients in the same age group wiLh larger invasive tumours (2.5- 
4,5 cm); 95%  confidence intervals are given in parentheses
4 0 4 9
Ago at diagnosis (years)
5 0 -6 9 2?70
Tum our size (cm) 
^  1 cm
1.5
0.37 
(0.14 1.00) 
0.56 
(0.24 1.31) 
0.81 
(0,40- 1*61)
0.26 
(0.15-0.45) 
0.35 
(0,20 0.61) 
0.88 
(0.57 1.3«)
0.17 
(0.05 0,55) 
0.44 
(0,20 0,98) 
0.51 
10.24-1.05)
Table H H azard ratio of dying from breast cancer for patients 
diagnosed with early invasive breast cancer (s£2 cm) with reference 
to patients in the same age group with larger invasive tumours (2.5 
4.5 cm), 95% adjusted for detection mode (screen-detected or 
clinically diagnosed); confidence intervals are given in parentheses
Age at diagnosis (years)
40 49 50 69 ‘ >70
T u m o u r size (cm) 
<  1 cm
1.5
2
0.38 
(0.14 1.02) 
0.58 
(0.25 1.35) 
0.82 
(0.41 1.64)
0.31 
(0.17 0.56) 
0.40 
(0.23 - 0.69) 
0.94 
(0.60 1.48)
0.2
(0 .0 6 -0 .7 1) 
0.53 
(0,23 1,21) 
0.56 
(0.27 1.17)
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Discussion
The purpose of mammographic screening is to detect cancers 
early in their development. However, a lower malignant 
potential of screen-detected cancers may limit the effective­
ness of screening in saving lives. Few data are currently 
available on the prognosis of patients with small breast 
cancers, particularly of those detected at screening.
In our study we confirmed, age specifically, the good 
prognosis of patients with cancers 1 cm or smaller, as was 
demonstrated in other studies (Rosen et al., 1989; Rosner and 
Lane, 1990; Tabar et al., 1993; Byrne et al., 1994). In the 
youngest age group only 13% of patients with a tumour 
diameter of 1 cm or less died of breast cancer within 10 years. 
Similarly, in the older age groups these failure rates were only 
14% and 6% respectively,
On the other hand, the survival advantage for patients 
with early breast cancers larger than I cm differs with age. In 
the 40-49 age group no significant better breast cancer- 
specific survival could be demonstrated for patients with a 
tumour 1.5 or 2 cm in diameter compared with that of 
patients with a larger tumour of 2 .5-4 ,5  cm. In this age 
group a substantially better survival is gained only in cases 
where the tumour is 1 cm or less. For women in the age 
group 50-69 at diagnosis the break for a better survival is at
1.5 cm tumour size, rising to 2 cm for the >70 age group» 
compared with the survival of patients having larger tumours. 
Thus it seems to be more difficult to improve survival in 
younger patients. A similar conclusion was reached on the 
basis of the survival results in the Breast Cancer Detection 
Demonstration Project (BCDDP) (Byrne et al., 1994). In the 
BCDDP this finding was explained by a higher breast cancer 
survival rate of younger women with a larger tumour 
compared with that of older women having a tumour of 
the same size.
This differential effect of age on breast cancer-specific 
survival of patients with small tumours could explain why it 
is more difficult to achieve a beneficial effect on breast cancer 
mortality in women aged 4 0 -4 9  by mammographic screen­
ing. While on the one hand to gain survival advantage in this 
age group tumours have to be detected when they are very 
small, on the other hand it is more difficult to spot small 
malignant tumours in these patients, probably because of 
their frequently observed dense breast tissue (Ciatto and 
Zappa, 1993).
In our study, cancers of a diameter of 1.5 cm or less 
diagnosed in younger women have a greater potential for 
fatality than tumours of the same size in older women. This 
may be partly explained by an earlier metastatic spread 
indicated by more frequent axillary lymph node involvement. 
Since 1981, the axillary lymph nodes have been routinely
Table HI Axillary lymph node involvement by age and size
(invasive tumours only)
Age at diagnosis (years)
40 -  49 50-69 >70
Tum our size (cm)
« 1 42%(// =  26) 15% («= 100) 25%(// = 36)
1.5 62%(jj —39) 30%(n — 79) 21 % (?* — 34)
2 45%(/z =  38) 43%(/i = 63) 38%(/i - 4 5 )
2.5 “ 4.5 64%(/i =  39) 54% (n«99) 58%(« =  78)
> 5 91%(/7= 11) 80%(/ï = 30) 78%(« =  23)
examined histologically in the two Nijmegen hospitals. Cross­
classification of tumour size and lymph node status for the 
calendar period 1981-92 (see Table III) shows that younger 
patients with a tumour of 1.5 cm or less more frequently had 
lymph node metastasis than older patients with a tumour of 
the same size. Even after adjustment for nodal involvement in 
a proportional hazards model, there is still an indication that 
younger patients with a 1.5 cm or smaller tumour are at 
greater risk of dying from breast cancer than women in the 
age groups 50-69 and >70 [hazard ratio 2.7 (P = 0.07) and
7.6 (P^O.06) respectively]. One explanation may be that 
nodal involvement in older patients is biologically less 
important regarding risk of distant metastasis compared 
with node-positive younger patients. This is in line with the 
recently formulated theory of Heilman (Heilman, 1994).
Our results indicate that a reduction in breast cancer 
mortality might be expected in women younger than 50 years 
of age only if a substantial proportion of the invasive cancers 
are detected before their size exceeds 1 cm. However, this 
target is not achieved by film-screen mammography (Peer el 
al., 1994). The development of new technologies, such as 
digital mammography and magnetic resonance imaging, 
might offer better prospects in this regard. It is also 
important that small invasive tumours rather than ductal 
carcinomas in situ are detected at screening, as the proportion 
of in situ tumours that progress to a life-threatening disease is 
uncertain.
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